BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34776047)

  • 1. Evolution of Focal Therapy in Prostate Cancer: Past, Present, and Future.
    Arcot R; Polascik TJ
    Urol Clin North Am; 2022 Feb; 49(1):129-152. PubMed ID: 34776047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.
    Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG
    World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to select the right patients for focal therapy of prostate cancer?
    Passoni NM; Polascik TJ
    Curr Opin Urol; 2014 May; 24(3):203-8. PubMed ID: 24625428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy strategies for selecting patients for focal therapy for prostate cancer.
    Kanthabalan A; Emberton M; Ahmed HU
    Curr Opin Urol; 2014 May; 24(3):209-17. PubMed ID: 24670871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.
    Muller BG; van den Bos W; Pinto PA; de la Rosette JJ
    Curr Opin Urol; 2014 May; 24(3):218-24. PubMed ID: 24637316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal therapy for prostate cancer: concepts and future directions.
    Ashrafi AN; Tafuri A; Cacciamani GE; Park D; de Castro Abreu AL; Gill IS
    Curr Opin Urol; 2018 Nov; 28(6):536-543. PubMed ID: 30102623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer multifocality, the index lesion, and the microenvironment.
    Tourinho-Barbosa RR; de la Rosette J; Sanchez-Salas R
    Curr Opin Urol; 2018 Nov; 28(6):499-505. PubMed ID: 30138121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR-guided biopsy and focal therapy: new options for prostate cancer management.
    Elkhoury FF; Simopoulos DN; Marks LS
    Curr Opin Urol; 2018 Mar; 28(2):93-101. PubMed ID: 29232269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.
    Sidelsky S; Setia S; Vourganti S
    Curr Urol Rep; 2017 Oct; 18(12):93. PubMed ID: 29046984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New advances in focal therapy for early stage prostate cancer.
    Tay KJ; Schulman AA; Sze C; Tsivian E; Polascik TJ
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):737-743. PubMed ID: 28635336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
    Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
    AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.
    Shoji S; Hiraiwa S; Hanada I; Kim H; Nitta M; Hasegawa M; Kawamura Y; Hashida K; Tajiri T; Miyajima A
    Int J Clin Oncol; 2020 Apr; 25(4):509-520. PubMed ID: 32040781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status and progress of focal therapy in Asia.
    Shiraishi T; Ukimura O
    Curr Opin Urol; 2018 Nov; 28(6):529-535. PubMed ID: 30102622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted prostate biopsy and MR-guided therapy for prostate cancer.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Abdom Radiol (NY); 2016 May; 41(5):877-88. PubMed ID: 26907717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer: state of the art imaging and focal treatment.
    Woodrum DA; Kawashima A; Gorny KR; Mynderse LA
    Clin Radiol; 2017 Aug; 72(8):665-679. PubMed ID: 28385253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
    Eggener SE; Yousuf A; Watson S; Wang S; Oto A
    J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-Analysis.
    Goldberg H; Ahmad AE; Chandrasekar T; Klotz L; Emberton M; Haider MA; Taneja SS; Arora K; Fleshner N; Finelli A; Perlis N; Tyson MD; Klaassen Z; Wallis CJD
    J Urol; 2020 Jun; 203(6):1085-1093. PubMed ID: 31609177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal Ablation of Early-Stage Prostate Cancer: Candidate Selection, Treatment Guidance, and Assessment of Outcome.
    Edison E; Tariq Shah T; Ahmed HU
    Urol Clin North Am; 2017 Nov; 44(4):575-585. PubMed ID: 29107274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal therapy of prostate and kidney cancer.
    Aminsharifi A; de la Rosette J; Polascik TJ
    Curr Opin Urol; 2018 Nov; 28(6):491-492. PubMed ID: 30239417
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
    Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
    J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.